16-26 of 26
Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
MinuteCE®Evolving Therapy for Managing Pediatric Narcolepsy: Wake-Promoting Pitolisant
Funke Afolabi-Brown, MD
Duchenne Muscular Dystrophy: Differentiating Advances in Treatment
CME/CEDuchenne Muscular Dystrophy: Differentiating Advances in Treatment
Omer Abdul Hamid, MD
Nancy Kuntz, MD
Migvis Monduy, MD
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®Therapeutic Options for ADH1 and Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®CASR and ADH1: Integrating Biology and Genetic Screening
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®Emerging Therapeutics in ADH1: Progress in Precision Medicine
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
- advertisement
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CETitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
Danielle Becker, MD, MS, FAES
Ahmed Abdelmoity, MD
Deborah Holder, MD
John Stern, MD
Evolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
CME/CEEvolving Perspectives in PIK3CA-related Overgrowth Spectrum Diagnosis & Treatment
William Mencia, MD, FACEHP
Julie Blatt, MD
Taizo Nakano, MD
Combining Biologics in a Young Patient with Atopic Dermatitis
CME/CECombining Biologics in a Young Patient with Atopic Dermatitis
Peter A. Lio, MD
Mark Boguniewicz, MD
Eric Simpson, MD, MCR
Peter A. Lio, MD
Mark Boguniewicz, MD
Eric Simpson, MD, MCR
- advertisement
